1. Cell Biology
  2. Developmental Biology

Kindlin-2 inhibits TNF/NF-κB-Caspase 8 pathway in hepatocytes to maintain liver development and function

  1. Huanqing Gao
  2. Yiming Zhong
  3. Liang Zhou
  4. Sixiong Lin
  5. Xiaoting Hou
  6. Zhen Ding
  7. Yan Li
  8. Qing Yao
  9. Huiling Cao
  10. Xuenong Zou
  11. Di Chen
  12. Xiaochun Bai  Is a corresponding author
  13. Guozhi Xiao  Is a corresponding author
  1. Southern Taiwan University of Science and Technology, China
  2. Southern University of Science and Technology, China
  3. Sun Yat-sen University, China
  4. Chinese Academy of Sciences, China
  5. Southern Medical University, China
https://doi.org/10.7554/eLife.81792
Share this article
Cite this article
  1. Huanqing Gao
  2. Yiming Zhong
  3. Liang Zhou
  4. Sixiong Lin
  5. Xiaoting Hou
  6. Zhen Ding
  7. Yan Li
  8. Qing Yao
  9. Huiling Cao
  10. Xuenong Zou
  11. Di Chen
  12. Xiaochun Bai
  13. Guozhi Xiao
(2023)
Kindlin-2 inhibits TNF/NF-κB-Caspase 8 pathway in hepatocytes to maintain liver development and function
eLife 12:e81792.
https://doi.org/10.7554/eLife.81792
  2. Download BibTeX
  3. Download .RIS

Abstract

Inflammatory liver diseases are a major cause of morbidity and mortality worldwide; however, underlying mechanisms are incompletely understood. Here we show that deleting the focal adhesion protein Kindlin-2 expression in hepatocytes using the Alb-Cre transgenic mice causes a severe inflammation, resulting in premature death. Kindlin-2 loss accelerates hepatocyte apoptosis with subsequent compensatory cell proliferation and accumulation of the collagenous extracellular matrix, leading to massive liver fibrosis and dysfunction. Mechanistically, Kindlin-2 loss abnormally activates the tumor necrosis factor (TNF) pathway. Blocking activation of the TNF signaling pathway by deleting TNF receptor or deletion of Caspase 8 expression in hepatocytes essentially restores liver function and prevents premature death caused by Kindlin-2 loss. Finally, of translational significance, adeno-associated virus mediated overexpression of Kindlin-2 in hepatocytes attenuates the D-galactosamine and lipopolysaccharide-induced liver injury and death in mice. Collectively, we establish that Kindlin-2 acts as a novel intrinsic inhibitor of the TNF pathway to maintain liver homeostasis and may define a useful therapeutic target for liver diseases.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1-7 and supplementary figures.

Article and author information

Author details

  1. Huanqing Gao

    Department of Biochemistry, Southern Taiwan University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8567-3583

  2. Yiming Zhong

    Department of Biochemistry, Southern University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.

  3. Liang Zhou

    Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, Sun Yat-sen University, Guangzhou, China
    Competing interests
    No competing interests declared.

  4. Sixiong Lin

    Department of Spinal Surgery, Sun Yat-sen University, Guangzhou, China
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7155-5044

  5. Xiaoting Hou

    Department of Biochemistry, Southern University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.

  6. Zhen Ding

    Department of Biochemistry, Southern University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.

  7. Yan Li

    Department of Biology, Southern University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.

  8. Qing Yao

    Department of Biochemistry, Southern University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.

  9. Huiling Cao

    Department of Biochemistry, Southern University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.

  10. Xuenong Zou

    Department of Spinal Surgery, Sun Yat-sen University, Guangzhou, China
    Competing interests
    No competing interests declared.

  11. Di Chen

    Research Center for Computer-aided Drug Discovery, Chinese Academy of Sciences, Shenzhen, China
    Competing interests
    Di Chen, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4258-3457

  12. Xiaochun Bai

    Department of Cell Biology, Southern Medical University, Guangzhou, China
    For correspondence
    baixc15@smu.edu.cn
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9631-4781

  13. Guozhi Xiao

    Department of Biochemistry, Southern University of Science and Technology, Shenzhen, China
    For correspondence
    xiaogz@sustech.edu.cn
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4269-2450

Funding

National Key Research and Development Program of China (2019YFA0906004)

  • Guozhi Xiao

National Natural Science Foundation of China (82230081,82250710175,82172375,81991513 and 81870532)

  • Guozhi Xiao

Shenzhen Municipal Science and Technology Innovation Council (JCYJ20180302174246105)

  • Huanqing Gao

Shenzhen Municipal Science and Technology Innovation Council (JCYJ20220818100617036，ZDSYS20140509142721429)

  • Guozhi Xiao

Guangdong Provincial Science and Technology Innovation Council Grant (2017B030301018)

  • Guozhi Xiao

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were approved and conducted in the specific pathogen free (SPF) Experimental Animal Center of Southern University of Science and Technology (Approval number: 20200074).

Copyright

© 2023, Gao et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 895
    views
  • 175
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Huanqing Gao
  2. Yiming Zhong
  3. Liang Zhou
  4. Sixiong Lin
  5. Xiaoting Hou
  6. Zhen Ding
  7. Yan Li
  8. Qing Yao
  9. Huiling Cao
  10. Xuenong Zou
  11. Di Chen
  12. Xiaochun Bai
  13. Guozhi Xiao
(2023)
Kindlin-2 inhibits TNF/NF-κB-Caspase 8 pathway in hepatocytes to maintain liver development and function
eLife 12:e81792.
https://doi.org/10.7554/eLife.81792

Share this article

https://doi.org/10.7554/eLife.81792

Categories and tags

Research organism

Further reading

    1. Cell Biology

    Stratification of enterochromaffin cells by single-cell expression analysis

    Yan Song, Linda J Fothergill ... Gene W Yeo
    Research Article

    Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.

    1. Cell Biology

    Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis

    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology
    2. Developmental Biology

    Lens Development: Bringing signaling complexity into focus

    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.